Véronique Vergé

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag, Serge Koscielny, Jacques Bosq et al. · The Lancet · 2016 · 187 citations

Medicine, Oncology, Pharmacotherapy +9

Cutting Edge Communication: In Vitro Generation of Dendritic Cells from Human Blood Monocytes in Experimental Conditions Compatible for In Vivo Cell Therapy

Hua Cao, Véronique Vergé, Carole Baron et al. · Journal of Hematotherapy & Stem Cell Research · 2000 · 50 citations

Life Sciences, Cell Biology, Immunology +17

Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia

Christophe Willekens, Samy Chraïbi, Justine Decroocq et al. · Blood · 2022 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +6

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience

Vincent Marmouset, Justine Decroocq, Sylvain Garciaz et al. · Clinical Cancer Research · 2022 · 28 citations · Full text

Medicine, Hematology, Oncology +16

Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures

Marie‐Catherine Giarratana, Véronique Vergé, Christian Schmitt et al. · Experimental Hematology · 2000 · 22 citations · Full text

Life Sciences, Cell Biology, Immunology +16